Perfil
Martin Henry Diggle founded Vulpes Investment Management Ltd., where he is working as Director & Partner from 2015.
Mr. Diggle also currently works at Vulpes Life Sciences Fund, as Chairman, Proteome Sciences Plc, as Non-Executive Director from 2014, Oxford BioDynamics Plc, as Non-Executive Director from 2026, and Vulpes Ventures, as Portfolio Manager.
Mr. Diggle also formerly worked at Oxford Biomedica Plc, as Non-Independent Non-Executive Director from 2012 to 2021, Brunswick UBS, as Director & Partner, Scancell Holdings Plc, as Non-Executive Director, Leucid Bio Ltd., as Director, and Chronos Therapeutics Ltd., as Non-Executive Director.
Mr. Diggle received his graduate degree from the University of Oxford.
Cargos activos de Martin Diggle
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTEOME SCIENCES PLC | Director/Miembro de la Junta | 16/10/2014 |
| OXFORD BIODYNAMICS PLC | Director/Miembro de la Junta | 15/04/2026 |
Vulpes Investment Management Ltd.
Vulpes Investment Management Ltd. Investment ManagersFinance Provides investment advice | Director/Miembro de la Junta | 27/03/2015 |
Vulpes Investment Management Pte Ltd. (Venture Capital)
Vulpes Investment Management Pte Ltd. (Venture Capital) Investment ManagersFinance Vulpes Ventures invests in companies located in Southeast Asia, Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Inversor de Capital Privado | - |
Vulpes Life Sciences Fund
Vulpes Life Sciences Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Presidente | - |
Antiguos cargos conocidos de Martin Diggle.
| Empresas | Cargo | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Director/Miembro de la Junta | 03/02/2021 |
Brunswick UBS
Brunswick UBS Investment Banks/BrokersFinance Operates as a investment bank | Director/Miembro de la Junta | 01/01/2003 |
Leucid Bio Ltd.
Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that develops next generation CAR-T therapy | Director/Miembro de la Junta | - |
| SCANCELL HOLDINGS PLC | Director/Miembro de la Junta | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Formación de Martin Diggle.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Proteome Sciences Plc
Proteome Sciences Plc Medical SpecialtiesHealth Technology Develops medical diagnostics used to identify specific diseases | Health Technology |
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brunswick UBS
Brunswick UBS Investment Banks/BrokersFinance Operates as a investment bank | Finance |
Scancell Holdings Plc
Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Oxford BioDynamics Plc
Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Vulpes Investment Management Ltd.
Vulpes Investment Management Ltd. Investment ManagersFinance Provides investment advice | Finance |
Vulpes Life Sciences Fund
Vulpes Life Sciences Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Miscellaneous |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Health Technology |
Vulpes Investment Management Pte Ltd. (Venture Capital)
Vulpes Investment Management Pte Ltd. (Venture Capital) Investment ManagersFinance Vulpes Ventures invests in companies located in Southeast Asia, Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Leucid Bio Ltd.
Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that develops next generation CAR-T therapy | Commercial Services |
- Bolsa de valores
- Insiders
- Martin Diggle
















